Hit or Miss

By Snyder, Karyn | Drug Topics, September 1, 1997 | Go to article overview

Hit or Miss


Snyder, Karyn, Drug Topics


OTC market growth is not problems

It's no secret that the nonprescription drug market keeps growing by leaps and bounds. A new report by Business Trend Analysts (BTA), a market research firm based in Commack, N.Y., examines some interesting factors responsible for the market's growth as well as some potential pitfalls.

For example, pharmaceutical companies have discovered that they can do much more to increase business other than just extend existing product lines. Rather than just adding new strengths or new delivery systems, such as caplets, gelcaps, and so on, they are adding new active ingredients to the nonprescription drug market. Recent Rx-to-OTC switches have contributed greatly to its growth. BTA attributes the marked growth of the OTC market in 1995 and 1996 to the Food & Drug Administration's approval of switches in the internal analgesic and antacid categories.

"As evidenced by trends in the pharmaceutical industry, it is believed that the only real chance for growth in the nonprescription drug market is the Rx-to-OTC switch. A newly reliable, available option for growth, the Rx-to-OTC switch overshadows the benefits of the line extension practice. With this option available, the game for the pharmaceutical manufacturer has become the drive to be the first to launch the product. This is the only way to carve a significant hold on the market," according to BTA.

Once products have been switched, consumer health-care companies do more than just market them to the average patient. BTA believes nonprescription drug companies have found a market in the managed care industry, but they should be wary of their new bedfellows. Complying with the desire of managed care organizations (MCOs) to keep health-care costs down, doctors have been prescribing more OTC products to their patients. On the surface, this looks like a promising deal for nonprescription drug manufacturers. However, BTA points out that many branded manufacturers may get the short end of the stick. According to the market research group, MCOs are increasingly working with private-label manufacturers to produce their own nonprescription products for members. In doing so, the MCOs not only cut costs but also increase their name recognition and their image as cost-effective health-care providers.

BTA also pointed out that pharmaceutical companies may erode their prescription markets by flooding shelves with over-the-counter products. The prescription antifungal and topical drug categories are particularly vulnerable in BTA's opinion. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Hit or Miss
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.